Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Zevra Therapeutics (ZVRA) Interest Coverage Ratio (2016 - 2025)

Zevra Therapeutics' Interest Coverage Ratio history spans 11 years, with the latest figure at 4.78 for Q4 2025.

  • For Q4 2025, Interest Coverage Ratio rose 168.05% year-over-year to 4.78; the TTM value through Dec 2025 reached 7.89, up 33.33%, while the annual FY2025 figure was 7.89, 33.33% up from the prior year.
  • Interest Coverage Ratio reached 4.78 in Q4 2025 per ZVRA's latest filing, up from 2.02 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 364.56 in Q2 2021 to a low of 568.4 in Q4 2021.
  • Average Interest Coverage Ratio over 5 years is 66.21, with a median of 23.67 recorded in 2023.
  • The largest YoY upside for Interest Coverage Ratio was 16729.21% in 2021 against a maximum downside of 35406.82% in 2021.
  • A 5-year view of Interest Coverage Ratio shows it stood at 568.4 in 2021, then surged by 95.2% to 27.29 in 2022, then rose by 26.53% to 20.05 in 2023, then skyrocketed by 64.95% to 7.03 in 2024, then soared by 168.05% to 4.78 in 2025.
  • Per Business Quant, the three most recent readings for ZVRA's Interest Coverage Ratio are 4.78 (Q4 2025), 2.02 (Q3 2025), and 35.36 (Q2 2025).